{"id":"https://openalex.org/W3011189708","doi":"https://doi.org/10.1158/2326-6066.cir-19-0745","title":"Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform","display_name":"Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform","publication_year":2020,"publication_date":"2020-03-17","ids":{"openalex":"https://openalex.org/W3011189708","doi":"https://doi.org/10.1158/2326-6066.cir-19-0745","mag":"3011189708","pmid":"https://pubmed.ncbi.nlm.nih.gov/32184297","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7310334"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-19-0745","doi":"https://doi.org/10.1158/2326-6066.cir-19-0745","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-19-0745","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2019/09/01/267047.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029670586","display_name":"Ron S. Gejman","orcid":"https://orcid.org/0000-0001-5138-2772","observed_orcids":["https://orcid.org/0000-0001-5138-2772"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ron S. Gejman","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","Tri-Institutional MD-PhD Program (MSKCC, Rockefeller University, Weill Cornell Medical College), New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","2Tri-Institutional MD-PhD Program (Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical College), New York, New York","3Weill Cornell Medicine, New York, New York"],"raw_orcid":"https://orcid.org/0000-0001-5138-2772","affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Tri-Institutional MD-PhD Program (MSKCC, Rockefeller University, Weill Cornell Medical College), New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466","https://openalex.org/I83399316"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"2Tri-Institutional MD-PhD Program (Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical College), New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466","https://openalex.org/I83399316"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043250867","display_name":"Heather F. Jones","orcid":"https://orcid.org/0000-0002-9459-377X","observed_orcids":["https://orcid.org/0000-0002-9459-377X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather F. Jones","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","3Weill Cornell Medicine, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-9459-377X","affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061721767","display_name":"Martin G. Klatt","orcid":"https://orcid.org/0000-0001-8703-7305","observed_orcids":["https://orcid.org/0000-0001-8703-7305"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin G. Klatt","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":"https://orcid.org/0000-0001-8703-7305","affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073815714","display_name":"Aaron Y. Chang","orcid":"https://orcid.org/0000-0002-7770-7405","observed_orcids":["https://orcid.org/0000-0002-7770-7405"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Y. Chang","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","3Weill Cornell Medicine, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-7770-7405","affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072042134","display_name":"Claire Y. Oh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire Y. Oh","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","3Weill Cornell Medicine, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020305680","display_name":"Smita S. Chandran","orcid":"https://orcid.org/0000-0001-9266-6878","observed_orcids":["https://orcid.org/0000-0001-9266-6878"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smita S. Chandran","raw_affiliation_strings":["Center for Cell Engineering and Department of Medicine, MSKCC, New York, NY, USA. 10065","Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","4Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell Engineering and Department of Medicine, MSKCC, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210109986"]},{"raw_affiliation_string":"4Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967771","display_name":"Tatiana Korontsvit","orcid":"https://orcid.org/0000-0001-6319-1797","observed_orcids":["https://orcid.org/0000-0001-6319-1797"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatiana Korontsvit","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030379024","display_name":"Viktoriya Zakahleva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktoriya Zakahleva","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062508226","display_name":"Tao Dao","orcid":"https://orcid.org/0000-0001-9937-6283","observed_orcids":["https://orcid.org/0000-0001-9937-6283"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Dao","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074579867","display_name":"Christopher Austin Klebanoff","orcid":"https://orcid.org/0000-0001-9645-3896","observed_orcids":["https://orcid.org/0000-0001-9645-3896"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher A. Klebanoff","raw_affiliation_strings":["Center for Cell Engineering and Department of Medicine, MSKCC, New York, NY, USA. 10065","Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","3Weill Cornell Medicine, New York, New York","4Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":"https://orcid.org/0000-0001-9645-3896","affiliations":[{"raw_affiliation_string":"Center for Cell Engineering and Department of Medicine, MSKCC, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210109986"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"4Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","Weill Cornell Medicine, New York, NY, USA. 10065","1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","3Weill Cornell Medicine, New York, New York","5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-4160-923X","affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Parker Institute for Cancer Immunotherapy, MSKCC, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210109986"]},{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA. 10065","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"3Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"5Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5006680533"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210109986","https://openalex.org/I4387153466"],"apc_list":null,"apc_paid":null,"fwci":2.0981,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.88396732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"8","issue":"5","first_page":"672","last_page":"684"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.2971000075340271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.06989999860525131,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-receptor-therapy","display_name":"T-cell receptor therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/mhc-class-i-ligands","display_name":"MHC class I ligands","score":0.7239999771118164},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cross-reactivity","display_name":"cross-reactivity","score":0.8930000066757202},{"id":"https://openalex.org/keywords/high-throughput-genetic-screening","display_name":"high-throughput genetic screening","score":0.6769999861717224},{"id":"https://openalex.org/keywords/t-cell-receptor-specificity","display_name":"T cell receptor specificity","score":0.3319999873638153},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C157764524","wikidata":"https://www.wikidata.org/wiki/Q1383412","display_name":"Throughput","level":3,"score":0.6993950009346008},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6079432368278503},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5650814771652222},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4449448883533478},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42325013875961304},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.4223085045814514},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40697431564331055},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.36552858352661133},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33014947175979614},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2571774423122406},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23377826809883118},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C555944384","wikidata":"https://www.wikidata.org/wiki/Q249","display_name":"Wireless","level":2,"score":0.0},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008285","descriptor_name":"Major Histocompatibility Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1158/2326-6066.cir-19-0745","doi":"https://doi.org/10.1158/2326-6066.cir-19-0745","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-19-0745","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"doi:10.1101/267047","doi":"https://doi.org/10.1101/267047","is_oa":true,"landing_page_url":"https://doi.org/10.1101/267047","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2019/09/01/267047.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:32184297","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32184297","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7310334","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7310334","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Immunol Res","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1101/267047","doi":"https://doi.org/10.1101/267047","is_oa":true,"landing_page_url":"https://doi.org/10.1101/267047","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2019/09/01/267047.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1358310196","display_name":null,"funder_award_id":"KL 3118/1-1","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G1574533925","display_name":"Immunobiology of Allogeneic Hematopoietic Cell Transplantation","funder_award_id":"P01CA023766","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2482401937","display_name":"Improving specificity of therapeutic antibodies for cancer.","funder_award_id":"R01CA055349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2900738668","display_name":"Targeted antigen receptor treatment of cancer","funder_award_id":"P01CA033049","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3595774636","display_name":null,"funder_award_id":"RO1CA55349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5019843938","display_name":"Immunoediting in Human Cancer","funder_award_id":"F30CA200327","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7335454695","display_name":"Cancer Pharmacology","funder_award_id":"T32CA062948","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8798105863","display_name":"Weill Cornell/Rockefeller/Sloan Kettering MST Program","funder_award_id":"T32GM007739","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000857803","display_name":"Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.","funder_award_id":"R35CA241894","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306271","display_name":"Damon Runyon Cancer Research Foundation","ror":"https://ror.org/01gd7b947"},{"id":"https://openalex.org/F4320306793","display_name":"Parker Foundation","ror":"https://ror.org/04nfmyz64"},{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320338388","display_name":"Eurostars","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3011189708.pdf","grobid_xml":"https://content.openalex.org/works/W3011189708.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1494978663","https://openalex.org/W1519533633","https://openalex.org/W1541199151","https://openalex.org/W1541816872","https://openalex.org/W1631589307","https://openalex.org/W1951588750","https://openalex.org/W1979731533","https://openalex.org/W1990602451","https://openalex.org/W1993001612","https://openalex.org/W1993446370","https://openalex.org/W2026876188","https://openalex.org/W2026920143","https://openalex.org/W2043080692","https://openalex.org/W2050302632","https://openalex.org/W2070748533","https://openalex.org/W2075216746","https://openalex.org/W2077864494","https://openalex.org/W2093966230","https://openalex.org/W2116640473","https://openalex.org/W2116863267","https://openalex.org/W2120344603","https://openalex.org/W2121315503","https://openalex.org/W2141609931","https://openalex.org/W2143626441","https://openalex.org/W2143970355","https://openalex.org/W2144242764","https://openalex.org/W2157384708","https://openalex.org/W2168688111","https://openalex.org/W2190996647","https://openalex.org/W2204515846","https://openalex.org/W2232549736","https://openalex.org/W2341538622","https://openalex.org/W2507608410","https://openalex.org/W2555228033","https://openalex.org/W2589139221","https://openalex.org/W2607497548","https://openalex.org/W2626596572","https://openalex.org/W2724264513","https://openalex.org/W2728365508","https://openalex.org/W2748343486","https://openalex.org/W2759890769","https://openalex.org/W2766820663","https://openalex.org/W2778215749","https://openalex.org/W2899327929","https://openalex.org/W2902524594"],"related_works":["https://openalex.org/W6991213325","https://openalex.org/W2964067915","https://openalex.org/W4308398380","https://openalex.org/W7171522370","https://openalex.org/W4385281984","https://openalex.org/W7118170370","https://openalex.org/W7202129234","https://openalex.org/W4416448616","https://openalex.org/W4415898819","https://openalex.org/W2756985129"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1],"receptor":[2],"(TCR)\u2013based":[3],"therapeutic":[4,77],"cells":[5,22,42,102],"and":[6,43,71,103,128,132],"agents":[7,39,78],"have":[8,45,54],"emerged":[9],"as":[10],"a":[11,56],"new":[12],"class":[13],"of":[14,37,75,82,100,118],"effective":[15],"cancer":[16],"therapies.":[17],"These":[18],"therapies":[19],"work":[20],"on":[21,32],"that":[23,62,90,121,133],"express":[24],"intracellular":[25],"cancer-associated":[26],"proteins":[27],"by":[28,138],"targeting":[29],"peptides":[30],"displayed":[31],"MHC":[33],"receptors.":[34],"However,":[35],"cross-reactivities":[36],"these":[38],"to":[40,95],"off-target":[41],"tissues":[44],"resulted":[46],"in":[47,108],"serious,":[48],"sometimes":[49],"fatal,":[50],"adverse":[51],"events.":[52],"We":[53,115],"developed":[55],"high-throughput":[57],"genetic":[58],"platform":[59],"(termed":[60],"\u201cPresentER\u201d)":[61],"encodes":[63],"MHC-I":[64,83,119],"peptide":[65],"minigenes":[66],"for":[67],"functional":[68],"immunologic":[69],"assays":[70,111],"determines":[72],"the":[73,97],"reactivities":[74],"TCR-like":[76],"against":[79],"large":[80],"libraries":[81],"ligands.":[84],"In":[85],"this":[86],"article,":[87],"we":[88],"demonstrated":[89],"PresentER":[91],"could":[92],"be":[93],"used":[94],"identify":[96],"on-and-off":[98],"targets":[99],"T":[101],"TCR-mimic":[104],"(TCRm)":[105],"antibodies":[106,127],"using":[107],"vitro":[109],"coculture":[110],"or":[112],"binding":[113],"assays.":[114],"found":[116],"dozens":[117],"ligands":[120],"were":[122,134],"cross-reactive":[123],"with":[124],"two":[125,129],"TCRm":[126],"native":[130],"TCRs":[131],"not":[135],"easily":[136],"predictable":[137],"other":[139],"methods.":[140]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2020-03-23T00:00:00"}